Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | FPR2 | P25090 | 4/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.34 |
| ▸ | NPY4R | P50391 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12763990 | 0.93 | TGM2 (0.39) | TGM2CHRM1FPR2SLC6A4NPY4R | |
| SCHEMBL12763955 | 0.86 | TGM2 (0.44) | TGM2CHRM1FPR2SLC6A4NPY4R | |
| SCHEMBL12763950 | 0.84 | FPR2 (0.38) | TGM2CHRM1FPR2SLC6A4NPY4R | |
| SCHEMBL12763956 | 0.83 | FPR2 (0.38) | TGM2CHRM1FPR2SLC6A4NPY4R | |
| SCHEMBL12764001 | 0.82 | — | — | |
| SCHEMBL14077999 | 0.79 | TGM2 (0.52) | TGM2CHRM1FPR2SLC6A4NPY4R | |
| SCHEMBL12763963 | 0.75 | — | — | |
| SCHEMBL12763952 | 0.75 | MEN1 (0.44) | TGM2CHRM1FPR2NPY4RMEN1 | |
| SCHEMBL12763957 | 0.74 | FPR2 (0.43) | TGM2CHRM1FPR2MEN1USP2 | |
| SCHEMBL12017847 | 0.72 | MEN1 (0.53) | TGM2CHRM1FPR2SLC6A4NPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9228225-B2 | Xanthene dyes | BIOSEARCH TECHNOLOGIES, INC. (US) | 2016-01-05 | — | — | US | disclosed |
| US-20110054165-A1 | XANTHENE DYES | BIOSEARCH TECHNOLOGIES, INC. (US) | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054165-A1 | XANTHENE DYES | ANXA5, ANTXR2, XPOT | TGM2 1403/4885CHRM1 532/4885FPR2 181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.